cyc 202 has been researched along with vanadates in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (vanadates) | Trials (vanadates) | Recent Studies (post-2010) (vanadates) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 5,200 | 7 | 785 |
| Protein | Taxonomy | cyc 202 (IC50) | vanadates (IC50) |
|---|---|---|---|
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 0.0254 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Keller, C; Krude, T | 1 |
1 other study(ies) available for cyc 202 and vanadates
| Article | Year |
|---|---|
Requirement of Cyclin/Cdk2 and protein phosphatase 1 activity for chromatin assembly factor 1-dependent chromatin assembly during DNA synthesis.
Topics: CDC2-CDC28 Kinases; Cell Cycle; Chromatin Assembly Factor-1; Chromosomal Proteins, Non-Histone; Cyclin A; Cyclin B; Cyclin B1; Cyclin D; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; DNA; DNA-Binding Proteins; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Glutathione Transferase; HeLa Cells; Humans; Kinetics; Mitosis; Models, Biological; Nucleosomes; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Purines; Recombinant Fusion Proteins; Recombinant Proteins; Roscovitine; Vanadates | 2000 |